Ieq Capital LLC Trims Stock Holdings in Xylem Inc. $XYL

Key Points

• Ieq Capital LLC reduced its stake in Xylem Inc. by 40.3%, owning 2,674 shares worth $319,000 after selling 1,803 shares in the first quarter.
• Multiple institutional investors increased their positions in Xylem, with Price T Rowe Associates raising its stake by 689.5% and acquiring over 3.2 million shares.
• Xylem reported earnings of $1.26 per share, beating estimates, with a revenue increase of 6.1% compared to the same quarter last year, and declared a quarterly dividend of $0.40.

Ieq Capital LLC cut its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 40.3% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,674 shares of the industrial products company's stock after selling 1,803 shares during the quarter. Ieq Capital LLC's holdings in Xylem were worth $319,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in XYL. Price T Rowe Associates Inc. MD boosted its position in shares of Xylem by 689.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock valued at $443,074,000 after purchasing an additional 3,239,203 shares in the last quarter. Nuveen LLC bought a new stake in Xylem in the first quarter worth $99,726,000. OVERSEA CHINESE BANKING Corp Ltd boosted its holdings in Xylem by 390.5% in the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock worth $122,009,000 after acquiring an additional 813,100 shares in the last quarter. Vaughan Nelson Investment Management L.P. bought a new stake in Xylem in the first quarter worth $89,828,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Xylem in the fourth quarter worth $83,139,000. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Performance

Xylem stock traded up $4.02 during mid-day trading on Thursday, reaching $141.75. 1,705,284 shares of the stock traded hands, compared to its average volume of 1,032,381. The stock has a market capitalization of $34.50 billion, a PE ratio of 36.82, a price-to-earnings-growth ratio of 2.38 and a beta of 1.09. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $145.33. The business's 50-day moving average is $138.01 and its 200-day moving average is $127.52.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.Xylem's revenue for the quarter was up 6.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, sell-side analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th will be given a $0.40 dividend. The ex-dividend date is Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem's dividend payout ratio is presently 41.56%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. TD Cowen boosted their target price on Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a report on Tuesday, August 26th. Cowen reissued a "hold" rating on shares of Xylem in a report on Tuesday, August 26th. Citigroup reissued a "buy" rating and issued a $152.00 target price (up from $137.00) on shares of Xylem in a report on Monday, July 14th. Raymond James Financial raised Xylem to a "hold" rating in a report on Thursday, May 15th. Finally, UBS Group upped their price target on Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a report on Tuesday, August 5th. Six equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $152.29.

Insider Buying and Selling

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company's stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the sale, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by insiders.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.